These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 25773655)

  • 1. Tocilizumab Dose Tapering Based on a Model-Based Algorithm is Feasible in Clinical Practice: A Short Communication.
    Hooijberg F; Layegh Z; Leeuw M; Boekel L; van den Berg SPH; Ruwaard J; Bastida C; Huitema ADR; Pel S; Elkayam O; de Vries A; Nurmohamed M; Rispens T; Dorlo TPC; Wolbink G
    Ther Drug Monit; 2024 Jun; 46(3):410-414. PubMed ID: 38287880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of tocilizumab in the treatment of rheumatoid arthritis.
    Okuda Y
    Biologics; 2008 Mar; 2(1):75-82. PubMed ID: 19707430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a non-medical switch from tocilizumab to upadacitinib in a cohort of patients with rheumatoid arthritis in routine clinical practice.
    White D; Poppelwell D
    N Z Med J; 2023 Aug; 136(1581):74-78. PubMed ID: 37619231
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of active rheumatoid arthritis with renal dysfunction treated effectively with tocilizumab monotherapy.
    Kato T; Koni I; Inoue R; Kitajima S; Kawano M; Yamagishi M
    Mod Rheumatol; 2009 Dec; ():. PubMed ID: 20037746
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioactive fractions and compound of Ardisia crispa roots exhibit anti-arthritic properties mediated via angiogenesis inhibition in vitro.
    Blin JA; Hamid RA; Khaza'ai H
    BMC Complement Med Ther; 2021 Jun; 21(1):176. PubMed ID: 34172047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tocilizumab Patterns of Use, Effectiveness, and Safety in Patients with Rheumatoid Arthritis: Final Results from a Set of Multi-National Non-Interventional Studies.
    Haraoui B; Casado G; Czirják L; Taylor A; Dong L; Button P; Luder Y; Caporali R
    Rheumatol Ther; 2019 Jun; 6(2):231-243. PubMed ID: 30859494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection.
    Biggioggero M; Crotti C; Becciolini A; Favalli EG
    Drug Des Devel Ther; 2019; 13():57-70. PubMed ID: 30587928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing the use of tocilizumab as monotherapy in patients with rheumatoid arthritis in a real-life setting: results at 1 year of the ACT-SOLO study.
    Flipo RM; Maillefert JF; Chazerain P; Idier I; Coudert M; Tebib J
    RMD Open; 2017; 3(1):e000340. PubMed ID: 28123778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis.
    Kihara M; Davies R; Kearsley-Fleet L; Watson KD; Lunt M; Symmons DP; Hyrich KL;
    Clin Rheumatol; 2017 Feb; 36(2):241-250. PubMed ID: 27913894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosing of Intravenous Tocilizumab in a Real-World Setting of Rheumatoid Arthritis: Analyses from the Corrona Registry.
    Pappas DA; John A; Curtis JR; Reed GW; Karki C; Magner R; Kremer JM; Shewade A; Greenberg JD
    Rheumatol Ther; 2016 Jun; 3(1):103-115. PubMed ID: 27747515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Switching within the active ingredient group or changing the mechanism of action. Data situation by failure of the first line biologic].
    Rubbert-Roth A
    Z Rheumatol; 2015 Jun; 74(5):406-13. PubMed ID: 26031285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocilizumab in patients with active rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs or tumor necrosis factor inhibitors: subanalysis of Spanish results of an open-label study close to clinical practice.
    Álvaro-Gracia JM; Fernández-Nebro A; García-López A; Guzmán M; Blanco FJ; Navarro FJ; Bustabad S; Armendáriz Y; Román-Ivorra JA;
    Reumatol Clin; 2014; 10(2):94-100. PubMed ID: 24099961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice.
    Bykerk VP; Östör AJ; Alvaro-Gracia J; Pavelka K; Román Ivorra JA; Graninger W; Bensen W; Nurmohamed MT; Krause A; Bernasconi C; Aassi M; Sibilia J
    Clin Rheumatol; 2015 Mar; 34(3):563-71. PubMed ID: 25604316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous tocilizumab: a review of its use in adults with rheumatoid arthritis.
    Dhillon S
    BioDrugs; 2014 Feb; 28(1):75-106. PubMed ID: 24255004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocilizumab: a review of its use in the management of rheumatoid arthritis.
    Oldfield V; Dhillon S; Plosker GL
    Drugs; 2009; 69(5):609-32. PubMed ID: 19368420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of use and dosing of tocilizumab in the treatment of patients with rheumatoid arthritis in routine clinical practice: the ACT-LIFE study.
    Balsa A; Tovar Beltrán JV; Cáliz Cáliz R; Mateo Bernardo I; García-Vicuña R; Rodríguez-Gómez M; Belmonte Serrano MA; Marras C; Loza Cortina E; Pérez-Pampin E; Vila V
    Rheumatol Int; 2015 Sep; 35(9):1525-34. PubMed ID: 25773655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ROUTINE-a prospective, multicentre, non-interventional, observational study to evaluate the safety and effectiveness of intravenous tocilizumab for the treatment of active rheumatoid arthritis in daily practice in Germany.
    Iking-Konert C; von Hinüber U; Richter C; Schwenke H; Gürtler I; Kästner P; Klapperich B; Peters MA; Burmester GR
    Rheumatology (Oxford); 2016 Apr; 55(4):624-35. PubMed ID: 26515959
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.